NO922291L - 7-azaisoindolinyl-kinolon- og naftyridonkarboksylsyrederivater - Google Patents
7-azaisoindolinyl-kinolon- og naftyridonkarboksylsyrederivaterInfo
- Publication number
- NO922291L NO922291L NO92922291A NO922291A NO922291L NO 922291 L NO922291 L NO 922291L NO 92922291 A NO92922291 A NO 92922291A NO 922291 A NO922291 A NO 922291A NO 922291 L NO922291 L NO 922291L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- amino
- methyl
- acid derivatives
- methylamino
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 3
- GRAHPXYWMKXSSJ-UHFFFAOYSA-N 3-(6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-7-yl)-1h-quinolin-2-one Chemical compound N1CC2=CC=CN=C2C1C1=CC2=CC=CC=C2NC1=O GRAHPXYWMKXSSJ-UHFFFAOYSA-N 0.000 title 1
- -1 methoxy, amino, methylamino, ethylamino Chemical group 0.000 abstract 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 abstract 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 239000004332 silver Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4121214A DE4121214A1 (de) | 1991-06-27 | 1991-06-27 | 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO922291D0 NO922291D0 (no) | 1992-06-11 |
| NO922291L true NO922291L (no) | 1992-12-28 |
Family
ID=6434855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92922291A NO922291L (no) | 1991-06-27 | 1992-06-11 | 7-azaisoindolinyl-kinolon- og naftyridonkarboksylsyrederivater |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5312823A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0520277A3 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH05213947A (cg-RX-API-DMAC7.html) |
| KR (1) | KR930000514A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1068114A (cg-RX-API-DMAC7.html) |
| AU (2) | AU647627B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2072207A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ192892A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE4121214A1 (cg-RX-API-DMAC7.html) |
| FI (1) | FI922953A7 (cg-RX-API-DMAC7.html) |
| HU (1) | HUT61545A (cg-RX-API-DMAC7.html) |
| IE (1) | IE922099A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL102288A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX9203228A (cg-RX-API-DMAC7.html) |
| NO (1) | NO922291L (cg-RX-API-DMAC7.html) |
| TW (1) | TW209218B (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA924743B (cg-RX-API-DMAC7.html) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4121214A1 (de) * | 1991-06-27 | 1993-01-14 | Bayer Ag | 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate |
| WO1994025464A1 (en) * | 1993-04-24 | 1994-11-10 | Korea Research Institute Of Chemical Technology | Novel quinolone carboxylic acid derivatives and process for preparing the same |
| DE4339134A1 (de) * | 1993-11-16 | 1995-05-18 | Bayer Ag | 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate |
| KR950018003A (ko) * | 1993-12-09 | 1995-07-22 | 스미스클라인 비참 피엘씨 | 신규한 퀴놀론 유도체 및 그의 제조 방법 |
| DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE4435479A1 (de) * | 1994-10-04 | 1996-04-11 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE19500792A1 (de) * | 1995-01-13 | 1996-07-18 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| US6608081B2 (en) | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| AU2002256995A1 (en) | 2001-02-07 | 2002-08-28 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| EP2305697A3 (en) | 2005-07-25 | 2011-07-27 | Intermune, Inc. | Macrocyclic inhibitors of Hepatitis C virus replication |
| FR2891274B1 (fr) * | 2005-09-27 | 2007-11-23 | Pierre Fabre Medicament Sa | Procede de preparation du (3-chloro-4-fluoro-phenyl)-(4- fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}- piperidin-1-yl)-methanone et nouveaux derives pyrimidiniques intermediaires. |
| CN102443015A (zh) * | 2010-10-13 | 2012-05-09 | 南京明生医药技术有限公司 | 一种7-取代喹啉羧酸衍生物及其制备方法和在抗菌抗结核上的应用 |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| CN103351348A (zh) * | 2013-07-15 | 2013-10-16 | 黄河三角洲京博化工研究院有限公司 | 一种2-甲胺基嘧啶盐酸盐的合成方法 |
| CA2923523A1 (en) | 2013-11-26 | 2015-06-04 | F. Hoffmann-La Roche Ag | New octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl |
| WO2015116904A1 (en) | 2014-02-03 | 2015-08-06 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ror-gamma |
| SG11201607839UA (en) | 2014-03-26 | 2016-10-28 | Hoffmann La Roche | Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| WO2016046837A1 (en) * | 2014-09-22 | 2016-03-31 | Cadila Healthcare Limited | An improved process for preparation of pyrrolo[3,4- c] pyrrole compounds and intermediates thereof |
| EA031967B1 (ru) | 2014-10-14 | 2019-03-29 | Вайтаи Фармасьютиклз, Инк. | ДИГИДРОПИРРОЛОПИРИДИНОВЫЕ ИНГИБИТОРЫ ROR-γ |
| US9845308B2 (en) | 2014-11-05 | 2017-12-19 | Vitae Pharmaceuticals, Inc. | Isoindoline inhibitors of ROR-gamma |
| US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| WO2016183741A1 (en) | 2015-05-15 | 2016-11-24 | Merck Sharp & Dohme Corp. | Pyrimidinone amide compounds as pde2 inhibitors |
| WO2017024018A1 (en) | 2015-08-05 | 2017-02-09 | Vitae Pharmaceuticals, Inc. | Modulators of ror-gamma |
| CA2992889A1 (en) | 2015-09-04 | 2017-03-09 | F. Hoffmann-La Roche Ag | Phenoxymethyl derivatives |
| CA2983782A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
| EP3353181B1 (en) | 2015-09-24 | 2021-08-11 | F. Hoffmann-La Roche AG | Bicyclic compounds as dual atx/ca inhibitors |
| JP6877413B2 (ja) * | 2015-09-24 | 2021-05-26 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 二重ａｔｘ／ｃａ阻害剤としての新規な二環式化合物 |
| US11008340B2 (en) | 2015-11-20 | 2021-05-18 | Vitae Pharmaceuticals, Llc | Modulators of ROR-gamma |
| TW202220968A (zh) | 2016-01-29 | 2022-06-01 | 美商維它藥物有限責任公司 | ＲＯＲ－γ調節劑 |
| US9481674B1 (en) | 2016-06-10 | 2016-11-01 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
| KR20190129924A (ko) | 2017-03-16 | 2019-11-20 | 에프. 호프만-라 로슈 아게 | 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 유용한 헤테로환형 화합물 |
| ES2788856T3 (es) | 2017-03-20 | 2020-10-23 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de quinasa de piruvato (PKR) |
| WO2019018975A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF ROR GAMMA |
| BR112020001246A2 (pt) | 2017-07-24 | 2020-07-21 | Vitae Pharmaceuticals, Llc | inibidores de rory |
| ES2989438T3 (es) | 2018-09-19 | 2024-11-26 | Novo Nordisk Healthcare Ag | Activación de la piruvato cinasa R |
| WO2020061378A1 (en) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
| CN109942488A (zh) * | 2019-04-04 | 2019-06-28 | 山东省联合农药工业有限公司 | 一种喹啉羧酸酯类化合物及其制备方法与用途 |
| MA57202B1 (fr) | 2019-09-19 | 2025-09-30 | Novo Nordisk Health Care Ag | Compositions d'activation de la pyruvate kinase r (pkr) |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
| CN116941624A (zh) * | 2021-04-29 | 2023-10-27 | 山东省联合农药工业有限公司 | 一种杀菌杀虫组合物及其应用 |
| CN113307768B (zh) * | 2021-04-29 | 2023-12-12 | 中国农业科学院兰州畜牧与兽药研究所 | 喹诺酮类衍生物及其制备方法和用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| NZ208470A (en) * | 1983-07-18 | 1988-06-30 | Abbott Lab | 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such |
| NZ210847A (en) * | 1984-01-26 | 1988-02-29 | Abbott Lab | Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions |
| EP0154780B1 (en) * | 1984-01-26 | 1990-04-11 | Abbott Laboratories | Quinoline antibacterial compounds |
| DE3420743A1 (de) * | 1984-06-04 | 1985-12-05 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| WO1989005643A1 (en) * | 1987-12-18 | 1989-06-29 | Pfizer Inc. | Heterocyclic-substituted quinoline-carboxylic acids |
| JPH0262875A (ja) * | 1988-05-23 | 1990-03-02 | Wakunaga Pharmaceut Co Ltd | 新規イソインドリン誘導体 |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| KR910009333B1 (ko) * | 1989-10-23 | 1991-11-11 | 재단법인 한국화학연구소 | 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법 |
| KR910009330B1 (ko) * | 1989-10-23 | 1991-11-11 | 재단법인 한국화학연구소 | 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법 |
| DE4121214A1 (de) * | 1991-06-27 | 1993-01-14 | Bayer Ag | 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate |
| DE4123918A1 (de) * | 1991-07-19 | 1993-01-21 | Bayer Ag | 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren |
| KR930703292A (ko) * | 1991-12-27 | 1993-11-29 | 쿠사이 요시히로 | 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제 |
| TW209865B (cg-RX-API-DMAC7.html) * | 1992-01-10 | 1993-07-21 | Bayer Ag |
-
1991
- 1991-06-27 DE DE4121214A patent/DE4121214A1/de not_active Withdrawn
-
1992
- 1992-05-23 TW TW081104032A patent/TW209218B/zh active
- 1992-06-04 AU AU18030/92A patent/AU647627B2/en not_active Ceased
- 1992-06-08 CN CN92104542A patent/CN1068114A/zh active Pending
- 1992-06-11 NO NO92922291A patent/NO922291L/no unknown
- 1992-06-15 EP EP19920110043 patent/EP0520277A3/de not_active Withdrawn
- 1992-06-19 US US07/901,056 patent/US5312823A/en not_active Expired - Fee Related
- 1992-06-23 CZ CS921928A patent/CZ192892A3/cs unknown
- 1992-06-24 CA CA002072207A patent/CA2072207A1/en not_active Abandoned
- 1992-06-24 MX MX9203228A patent/MX9203228A/es unknown
- 1992-06-24 IL IL102288A patent/IL102288A0/xx unknown
- 1992-06-25 JP JP4190249A patent/JPH05213947A/ja active Pending
- 1992-06-25 FI FI922953A patent/FI922953A7/fi unknown
- 1992-06-26 HU HU9202145A patent/HUT61545A/hu unknown
- 1992-06-26 KR KR1019920011212A patent/KR930000514A/ko not_active Withdrawn
- 1992-06-26 ZA ZA924743A patent/ZA924743B/xx unknown
- 1992-07-01 IE IE209992A patent/IE922099A1/en not_active Application Discontinuation
-
1994
- 1994-01-06 AU AU53040/94A patent/AU5304094A/en not_active Abandoned
- 1994-02-18 US US08/199,371 patent/US5371090A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR930000514A (ko) | 1993-01-15 |
| IE922099A1 (en) | 1992-12-30 |
| CA2072207A1 (en) | 1992-12-28 |
| MX9203228A (es) | 1992-12-01 |
| AU5304094A (en) | 1994-03-03 |
| HU9202145D0 (en) | 1992-10-28 |
| EP0520277A2 (de) | 1992-12-30 |
| ZA924743B (en) | 1993-03-31 |
| US5312823A (en) | 1994-05-17 |
| NO922291D0 (no) | 1992-06-11 |
| HUT61545A (en) | 1993-01-28 |
| FI922953A0 (fi) | 1992-06-25 |
| AU647627B2 (en) | 1994-03-24 |
| AU1803092A (en) | 1993-01-07 |
| US5371090A (en) | 1994-12-06 |
| EP0520277A3 (en) | 1993-01-13 |
| CZ192892A3 (en) | 1993-01-13 |
| JPH05213947A (ja) | 1993-08-24 |
| IL102288A0 (en) | 1993-01-14 |
| CN1068114A (zh) | 1993-01-20 |
| TW209218B (cg-RX-API-DMAC7.html) | 1993-07-11 |
| DE4121214A1 (de) | 1993-01-14 |
| FI922953A7 (fi) | 1992-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO922291L (no) | 7-azaisoindolinyl-kinolon- og naftyridonkarboksylsyrederivater | |
| PL292101A1 (en) | Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine | |
| DK616388A (da) | Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning | |
| OA06263A (fr) | Dérivés acylés. | |
| DK538886D0 (da) | 3-oxadiazol- og 3-carbonsyre-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel | |
| LV5269A3 (lv) | Pristinamicina p beta atvasinajumu iegusanas panemiens izomeru vai to maisijuma veida vai skabju-aditivo saju veida | |
| SE7710873L (sv) | Nya 1h-pyrazolo(3,4-b)pyridiner | |
| ES8801273A1 (es) | Un procedimiento para la preparacion de nuevos derivados de purina | |
| DE68919945D1 (de) | Substituierte beta-Diketone. | |
| DK327286A (da) | Indolcarboxamidderivater og salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter til deres fremstilling | |
| NZ238226A (en) | 2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl purine and pyrimidine derivatives, intermediates and their preparation | |
| SE8003466L (sv) | Alkyloximsubstituerade 7-(2-amino-4-tiazolyl)-acetamido-cefalosporansyraderivat, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar | |
| DE69226951D1 (de) | Antibiotische carbapenemderivate | |
| IL74556A (en) | Derivatives of 1,5-diaryl-1,2,4-thiadiazine 1-oxide,their preparation and pharmaceutical compositions containing them | |
| FI853866L (fi) | 2-pyridin-tiol-derivat, foerfarande foer framstaellning av dessa samt farmaceutiska foereningar innehaollande dessa. | |
| DK96086A (da) | 8-thiotetrahydroquinolinderivater, deres fremstilling og anvendelse som laegemidler | |
| ES442217A1 (es) | Procedimiento para la obtencion de derivados cefem. | |
| DK0538517T3 (da) | Nye organo-tinforbindelser med antitumoraktivitet og antitumormidler | |
| IE873442L (en) | Cephalosporin derivative | |
| NZ221004A (en) | 2,6-piperazinediones and pharamceutical compositions | |
| DE69301639D1 (de) | Tetrahydronaphtalenderivate, ihre Herstellung und ihre therapeutische Verwendung | |
| GR3002417T3 (en) | Derivatives of 8-phenylthiotetrahydroquinolines and their salts, their synthesis for use as medicaments and compositions containing them | |
| SE8400451L (sv) | Bronkutvidgande azapinol(1-2-a)pyrimidinderivat och syraadditionssalter derav samt farmaceutiska kompositioner innehallande desamma | |
| KR940003960A (ko) | 신규한 세팔로스포린계 항생제 및 이의 제조방법(ⅱ) |